Eli Lilly
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Business
By Bhanvi Satija and Patrick Wingrove (Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly’s weight-loss drug Zepbound drove the company ...
Eli Lilly Just Announced More Good News: Time to Buy?
Health
The pharmaceutical business is a tricky one. Developing novel therapies costs hundreds of thousands of dollars, sometimes more. Many never make it ...
Forget Nvidia, These Unstoppable Stocks Are Better Buys
Business
Nvidia has been an amazing stock to own over the past few years, generating incredible returns for investors. But the risk is ...
3 Dividend Stocks to Buy and Hold for the Next Decade
Business
Buy, hold, rake in solid income. That sounds like a pretty good investing strategy. You only have to find the right stocks ...
Meet the 5 Stocks That Have Contributed Almost All of the S&P 500’s 2024 Gains
Business
Containing the 500 largest publicly-traded U.S. companies by market cap, the S&P 500 is arguably the best indicator of the performance of ...
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock.
Business
Eli Lilly and Novo Nordisk have been among the hottest healthcare stocks to own over the past few years. Since 2021, shares ...
Most People Who Stop Taking Wegovy/Ozempic Keep the Weight Off, Study Finds
Health
A popular class of weight loss drugs may offer more lasting success than assumed, new data from Epic Research suggests. The study ...
Eli Lilly stock could soar 140% by 2028 as more people use weight-loss drugs, Goldman says
Business
Sandy Huffaker for The Washington Post via Getty Images Eli Lilly stock could soar 140% by 2028 as millions of Americans begin ...
still seeking UK approval on pen for weight-loss drug
U.S.
By Maggie Fick and Ludwig Burger LONDON (Reuters) -Eli Lilly on Thursday said it has not yet gained approval in Britain for ...
Apple earnings, Jamie Dimon interview: What to Watch
Trending
Yahoo Finance Live anchor Josh Lipton looks ahead to the earnings results due out from Apple (AAPL), Eli Lilly (LLY), and Paramount ...
